These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29366443)

  • 1. Hippo-YAP/TAZ signaling in angiogenesis.
    Park JA; Kwon YG
    BMB Rep; 2018 Mar; 51(3):157-162. PubMed ID: 29366443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding partners of YAP/TAZ.
    Kim MK; Jang JW; Bae SC
    BMB Rep; 2018 Mar; 51(3):126-133. PubMed ID: 29366442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry.
    Azad T; Ghahremani M; Yang X
    Cells; 2019 May; 8(5):. PubMed ID: 31052445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.
    Kim J; Kim YH; Kim J; Park DY; Bae H; Lee DH; Kim KH; Hong SP; Jang SP; Kubota Y; Kwon YG; Lim DS; Koh GY
    J Clin Invest; 2017 Sep; 127(9):3441-3461. PubMed ID: 28805663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells.
    Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A
    FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.
    Dai X; She P; Chi F; Feng Y; Liu H; Jin D; Zhao Y; Guo X; Jiang D; Guan KL; Zhong TP; Zhao B
    J Biol Chem; 2013 Nov; 288(47):34041-34051. PubMed ID: 24106267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
    Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Hippo Pathway Transcription Factor TEAD.
    Lin KC; Park HW; Guan KL
    Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.